Medscape Medical NewsAll articles

Sonix Health

Ontact Health Co., Ltd • Radiology • 11/27/2024

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

Sonix Health is a Class II medical device designed to automate echocardiography quantification and reporting for licensed physicians, aiming to enhance efficiency and accuracy in cardiac image analysis. It employs a two-step artificial intelligence algorithm to process DICOM-compliant ultrasound images, perform automated measurements and strain analysis, and has demonstrated high accuracy and correlation with manual expert measurements in performance testing.

Summary

Ontact Health Co., Ltd has received a determination that its Sonix Health device is substantially equivalent to existing legally marketed devices. This allows the company to market Sonix Health, which is classified as a Class II medical image management and processing system. The device is intended for use by or on the order of a licensed physician for quantifying and reporting echocardiography, accepting DICOM-compliant ultrasound images from B (2D), M, Pulsed-wave Doppler, and Continuous-wave Doppler modes for adult populations.Sonix Health is a software-only solution designed to be installed directly on a customer's PC hardware. It utilizes a two-step artificial intelligence algorithm to automate tasks such as checking multiframe DICOMs, classifying echocardiography multiframe DICOMs, and performing automatic measurements, while also allowing for manual verification and adjustment of results, and providing analysis reports. Non-clinical and standalone testing confirmed its performance and compliance with relevant standards, including IEC 62304 for software life cycle processes and ISO 14971 for risk management. Performance tests on patient images demonstrated high accuracy for view recognition and strong correlation coefficients for automated measurements and strain analysis compared to manual expert measurements, thereby confirming its design specifications and substantial equivalence.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Sonix HealthEchocardiographyMedical image managementArtificial intelligenceDICOM-compliantAutomated measurementsStrain analysisSubstantial equivalenceClass II medical deviceSoftware-only solution

Device Metadata

Submission Number
K240645
Company
Ontact Health Co., Ltd
Panel
Radiology
Product Code
N/A
Data Type
N/A
Clinical Function
N/A
AI Function
N/A
AI Subclass
N/A

Relevant Clinical Questions

  • Q1. How does the two-step AI algorithm specifically handle complex or atypical echocardiography images that might challenge current manual interpretation?; What are the specific clinical scenarios or patient populations where Sonix Health's automated measurements and strain analysis show the most significant diagnostic or prognostic value?; Beyond view recognition and automated measurements, what other advanced analytical capabilities could be integrated into Sonix Health to further assist clinicians?; Given its software-only nature, what cybersecurity measures are in place to protect patient data and ensure the integrity of the AI algorithm on a customer's PC hardware?; What is the long-term plan for post-market surveillance and continuous improvement of the AI algorithm's accuracy, especially as new echocardiography techniques or pathologies emerge?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score45/100
SBOM Evidence⚠ Not in summary - likely in full submission per §524B
Cyber Risk Assessment✓ Detected in Summary
Postmarket Plan✓ Detected in Summary
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(algorithm)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials
- Not detected
HBOMHardware Bill of Materials(hardware)
✓ Detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, HBOM detected in AI-generated device summary.

• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.

• Not detected in AI-generated device summary: SBOM, SaaSBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Sonix Health - Ontact Health Co., Ltd | ESL FDA AI Device Intelligence